Found: 8
Select item for more details and to access through your institution.
JMJD3 regulates CD4 T cell trafficking by targeting actin cytoskeleton regulatory gene Pdlim4.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Identification of Special AT-Rich Sequence Binding Protein 1 as a Novel Tumor Antigen Recognized by CD8<sup>+</sup> T Cells: Implication for Cancer Immunotherapy.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056730
- By:
- Publication type:
- Article
Identification of Prostate-Specific G-Protein Coupled Receptor as a Tumor Antigen Recognized by CD8<sup>+</sup> T Cells for Cancer Immunotherapy.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0045756
- By:
- Publication type:
- Article
Addendum: USP3 plays a critical role in the induction of innate immune tolerance.
- Published in:
- EMBO Reports, 2024, v. 25, n. 4, p. 2146, doi. 10.1038/s44319-024-00096-8
- By:
- Publication type:
- Article
USP3 plays a critical role in the induction of innate immune tolerance.
- Published in:
- EMBO Reports, 2023, v. 24, n. 12, p. 1, doi. 10.15252/embr.202357828
- By:
- Publication type:
- Article
Beclin 2 negatively regulates innate immune signaling and tumor development.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer.
- Published in:
- International Journal of Cancer, 2014, v. 134, n. 3, p. 587, doi. 10.1002/ijc.28389
- By:
- Publication type:
- Article
Immunotherapeutic Potential of Anti-Human Endogenous Retrovirus-K Envelope Protein Antibodies in Targeting Breast Tumors.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 3, p. 189, doi. 10.1093/jnci/djr540
- By:
- Publication type:
- Article